Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SARS-CoV-2 Nucleocapsid antibody

This Human Monoclonal antibody specifically detects SARS-CoV-2 Nucleocapsid in ELISA and SDS. It exhibits reactivity toward SARS Coronavirus-2 (SARS-CoV-2).
Catalog No. ABIN6953177

Quick Overview for SARS-CoV-2 Nucleocapsid antibody (ABIN6953177)

Target

See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Antibodies
SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Reactivity

  • 85
  • 8
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SARS Coronavirus-2 (SARS-CoV-2)

Host

  • 34
  • 30
  • 24
  • 4
  • 1
  • 1
Human

Clonality

  • 71
  • 16
  • 6
Monoclonal

Conjugate

  • 71
  • 15
  • 5
  • 1
  • 1
This SARS-CoV-2 Nucleocapsid antibody is un-conjugated

Application

  • 83
  • 39
  • 11
  • 10
  • 9
  • 6
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, SDS-PAGE (SDS)
  • Purpose

    Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1

    Characteristics

    Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (ABIN6953177) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293).

    Purity

    > 95 % as determined by SDS-PAGE.

    Sterility

    0.22 μm filtered

    Isotype

    IgG1
  • Restrictions

    For Research Use only
  • Format

    Lyophilized

    Buffer

    Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4 . Normally trehalose is added as protectant before lyophilization.

    Handling Advice

    Please avoid repeated freeze-thaw cycles.

    Storage

    4 °C,-20 °C,-80 °C

    Storage Comment

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.
    This product is stable after storage at:
    4-8°C for 12 months in lyophilized state,
    -70°C for 3 years under sterile conditions after reconstitution.
  • Target

    SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

    Alternative Name

    SARS-CoV-2 Nucleocapsid Protein

    Target Type

    Viral Protein

    Background

    Nucleocapsid protein is a most abundant protein of coronavirus. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. While screening for ADP-ribosylated proteins during coronavirus (CoV) infection, we identified as the viral nucleocapsid (N) protein. Novel post-translation modification of the CoV N protein that may play a regulatory role for this important structural protein. The array of diverse functional activities accommodated in the hantaviral N protein goes far beyond to be a static structural protein and makes it an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
You are here:
Chat with us!